Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
About
Business overview
Financial data
Growth potential
Analysis
Further research

What is France Bed Holdings Co., Ltd. stock?

7840 is the ticker symbol for France Bed Holdings Co., Ltd., listed on TSE.

Founded in Mar 30, 2004 and headquartered in 2004, France Bed Holdings Co., Ltd. is a Medical Specialties company in the Health technology sector.

What you'll find on this page: What is 7840 stock? What does France Bed Holdings Co., Ltd. do? What is the development journey of France Bed Holdings Co., Ltd.? How has the stock price of France Bed Holdings Co., Ltd. performed?

Last updated: 2026-05-15 09:32 JST

About France Bed Holdings Co., Ltd.

7840 real-time stock price

7840 stock price details

Quick intro

France Bed Holdings Co., Ltd. (7840:JP) is a leading Japanese provider of medical beds and nursing care equipment. Its core business includes the rental and sale of welfare products (Medical Services) and high-quality home furniture (Home Furnishing & Health).

In FY2024, the company reported solid results with net sales of ¥59,151 million and an operating profit of ¥4,587 million. For FY2025, it maintains growth momentum, forecasting net sales to reach ¥60,561 million, driven by rising demand in Japan's aging society and strategic service realignments.

Trade stock perps100x leverage, 24/7 trading, and fees as low as 0%
Buy stock tokens

Basic info

NameFrance Bed Holdings Co., Ltd.
Stock ticker7840
Listing marketjapan
ExchangeTSE
FoundedMar 30, 2004
Headquarters2004
SectorHealth technology
IndustryMedical Specialties
CEOfrancebed-hd.co.jp
WebsiteTokyo
Employees (FY)1.81K
Change (1Y)+29 +1.63%
Fundamental analysis

France Bed Holdings Co., Ltd. Business Overview

France Bed Holdings Co., Ltd. (TYO: 7840) is a premier Japanese enterprise specializing in the manufacturing, sales, and leasing of high-quality bedding, furniture, and medical nursing equipment. While its name might suggest a European origin, it is a quintessentially Japanese brand that has evolved from a pioneer in Western-style beds to a critical infrastructure provider for Japan’s aging society.

Core Business Segments

1. Medical Services Business (The Primary Growth Engine):
This segment is the company's largest and most profitable division, accounting for over 60% of total net sales as of the FY2024 (ending March 2024). It focuses on the rental and sales of nursing care products covered by Japan’s Long-Term Care Insurance.

  • Rental Services: Providing electric nursing beds, wheelchairs, walkers, and oxygen concentrators to the elderly.
  • Maintenance: Operating high-standard cleaning and sterilization centers to ensure the safety and hygiene of recycled rental equipment.
2. Home Health Care Business (The Foundation):
This segment carries the legacy of the "France Bed" brand. It involves the manufacturing and distribution of premium beds, mattresses, and furniture for the general consumer market and the hospitality industry.
  • High-End Bedding: Utilizing "High-Density Continuous Spring" technology, which is unique to the brand in Japan.
  • Hotel & Contract: Supplying beds to luxury hotels and healthcare facilities across Japan.

Business Model Characteristics

Recurring Revenue via Rental: Unlike traditional furniture retailers, France Bed operates a "Stock-type" business model. By leasing nursing beds through the Long-Term Care Insurance system, the company generates stable, monthly recurring revenue that is less susceptible to economic downturns.
Integrated Supply Chain: The company controls the entire lifecycle of its products—from R&D and manufacturing to distribution, rental, and specialized sterilization.

Core Competitive Moat

1. High-Density Continuous Spring Technology: France Bed is the exclusive manufacturer in Japan using this technology, which offers superior durability and breathability, specifically suited for the Japanese climate and ergonomic needs.
2. Extensive Logistics and Maintenance Network: With over 60 "Medical Service Centers" across Japan, the company possesses a logistical barrier that is difficult for newcomers to replicate. Their proprietary sterilization processes set a high bar for hygiene standards in the rental market.
3. Trust and Brand Equity: Having been a household name for over 70 years, the "France Bed" brand is synonymous with quality and reliability, which is a decisive factor for elderly users and medical institutions.

Latest Strategic Layout

Under its "Medium-Term Management Plan 2024-2026," the company is focusing on:

  • Digital Transformation (DX): Implementing RFID tagging for all rental assets to optimize inventory management and tracking.
  • Silver-Tech Innovation: Developing "Monitoring Beds" equipped with sensors to track heart rate and respiratory patterns, catering to the labor shortage in nursing homes.
  • Sustainability: Expanding the "Life-Cycle Management" of products to reduce waste and carbon footprint.

France Bed Holdings Co., Ltd. History

The history of France Bed is a reflection of Japan’s modernization and its transition into a super-aging society.

Development Phases

Phase 1: Post-War Innovation (1946 – 1960s)
Founded in 1946 as "Sankyo Seisakusho" by Minoru Ikeda, the company initially manufactured seat covers for vehicles. In 1956, it launched the "France Bed," a folding sofa bed designed for small Japanese homes. The name was chosen to evoke an image of elegance and western luxury, which was highly sought after in the post-war era.

Phase 2: Popularizing the Bed Culture (1970s – 1980s)
As Japanese lifestyles shifted from "Futons" to "Beds," France Bed became a market leader. It established a nationwide network of showrooms and factories, cementing its position as the top domestic bed manufacturer.

Phase 3: Strategic Pivot to Medical Care (1990s – 2003)
Recognizing the early signs of Japan’s demographic shift, the company entered the welfare equipment rental business in 1983. In 2003, the company adopted a holding company structure to better manage its diversifying interests in furniture and medical services.

Phase 4: Consolidation and Growth (2004 – Present)
The company successfully navigated the transition where the Medical Services division surpassed the Furniture division in revenue. In recent years, it has focused on premiumization and high-tech nursing solutions.

Analysis of Success Factors

Adaptability: The most significant reason for France Bed’s longevity is its ability to pivot from a "Lifestyle/Luxury" brand to a "Healthcare/Necessity" brand. While many furniture competitors struggled with the rise of "fast furniture" (like Nitori or IKEA), France Bed insulated itself by dominating the regulated nursing care market.

Industry Overview

France Bed operates at the intersection of the Furniture Retail industry and the Medical/Nursing Care Equipment industry.

Market Trends and Catalysts

1. The "Super-Aging" Society: Japan has the highest proportion of elderly people globally. Over 29% of the population is aged 65 or older. This creates a permanent and growing demand for nursing beds and mobility aids.
2. In-Home Care Shift: The Japanese government is promoting "Home-based Care" to reduce the burden on hospitals. This policy directly benefits France Bed’s rental model for home-use medical beds.

Competitive Landscape

Competitor Primary Strength Market Position
Paramount Bed Holdings Hospital & Clinical Beds Dominant leader in clinical/hospital settings.
Nitori Holdings Mass Market Furniture Strong in low-to-mid price consumer bedding.
France Bed Holdings Nursing Rental & High-End Bedding Leader in the Long-term Care Insurance rental market.

Industry Data & Financial Highlights

According to recent financial reports (FY2024):

  • Net Sales: Approximately 57.5 billion JPY (up 3.5% YoY).
  • Operating Profit Margin: Maintained at a robust 7-8% range, driven by the high-margin rental business.
  • Dividend Policy: The company is known for shareholder-friendly policies, targeting a consolidated payout ratio of around 50%.

Industry Positioning

France Bed holds a unique "Hybrid" position. While it competes with furniture retailers for consumer mindshare, its true strength lies in being a **Top-Tier Provider of Welfare Equipment**. As the "Silver Market" continues to expand, France Bed is positioned not just as a bed maker, but as an essential service provider for the elderly, granting it a defensive quality that few other retail stocks possess.

Financial data

Sources: France Bed Holdings Co., Ltd. earnings data, TSE, and TradingView

Financial analysis
This financial analysis provides a comprehensive overview of **France Bed Holdings Co., Ltd. (TYO: 7840)**, a leading Japanese company specializing in medical-grade beds, nursing care equipment, and high-quality home furniture.

France Bed Holdings Co., Ltd. Financial Health Score

The financial health of France Bed Holdings is characterized by steady revenue growth and a very conservative balance sheet. The company maintains a strong equity-to-asset ratio, which is typical of established Japanese industrial firms focusing on the aging population sector.

Indicator Latest Value (FY2024/FY2025 Est.) Score (40-100) Rating
Solvency & Liquidity Current Ratio: 2.64 | Debt/Equity: 32.3% 92 ⭐️⭐️⭐️⭐️⭐️
Profitability Operating Margin: 7.4% | ROE: 6.9% 75 ⭐️⭐️⭐️⭐️
Revenue Growth FY2024 Revenue: ¥59.15B (+1.0% YoY) 70 ⭐️⭐️⭐️
Dividend Stability Payout Ratio: ~51.7% | Yield: ~3.05% 88 ⭐️⭐️⭐️⭐️
Overall Health Weighted Average 81 ⭐️⭐️⭐️⭐️

Data Source: Financial Highlights from France Bed Holdings (FY2024 actuals and FY2025/2026 forecasts).

France Bed Holdings Co., Ltd. Development Potential

1. Strategic Expansion in Medical & Nursing Care

As Japan’s "super-aging" society continues to expand, the demand for nursing care beds and assistive devices remains a primary growth driver. The company is shifting its focus from simple product sales to a subscription-based rental model for nursing care products. This provides a stable, recurring revenue stream that is less susceptible to economic fluctuations.

2. Technological Integration: Sensing and AI

The company is actively developing "Smart Beds" equipped with sensing technology to monitor sleep quality and vital signs. This innovation targets both the medical facility market (to reduce the burden on caregivers) and the premium consumer market (Health Promotion Business). The roadmap for 2026-2027 includes a target of ¥5 billion in sales for the Health Promotion segment alone.

3. Structural Reform of Home Furnishings

France Bed recently announced a structural reform of its Home Furnishings and Health business (September 2025 update). By consolidating showrooms and optimizing logistics, the company aims to improve the segment's profitability, which has historically lagged behind the medical division.

4. International Market Penetration

While Japan remains its core market, France Bed is looking toward China and Southeast Asia. By leveraging its expertise in hospital-grade equipment, the company is positioning itself to capture the emerging demand for high-quality elderly care in neighboring aging nations.

France Bed Holdings Co., Ltd. Company Pros and Risks

Company Pros (Bullish Factors)

+ High Recurring Revenue: The nursing care rental business provides high-visibility income, insulating the company from retail volatility.
+ Strong Dividend Policy: With a dividend yield consistently around 3% and a commitment to shareholder returns (including stock buybacks), the company is attractive to value investors.
+ Market Leader Advantage: France Bed holds a significant market share in the Japanese nursing bed industry, benefiting from high barriers to entry due to regulatory certifications and established hospital networks.

Company Risks (Bearish Factors)

- Rising Raw Material Costs: Volatility in steel, wood, and synthetic fiber prices, often exacerbated by yen fluctuations, can compress gross margins.
- Domestic Market Saturation: Despite the aging population, the Japanese market is highly competitive. Future growth relies heavily on the success of international expansion and high-tech product adoption.
- Regulatory Changes: The medical and nursing care business is sensitive to changes in Long-Term Care Insurance reimbursement rates in Japan, which are reviewed periodically by the government.

Analyst insights

How do Analysts View France Bed Holdings Co., Ltd. and the 7840 Stock?

As of mid-2024, analysts maintain a "cautiously optimistic" outlook on France Bed Holdings Co., Ltd. (TYO: 7840), a leader in the Japanese silver-age nursing bed and home furniture market. While the stock is often categorized as a defensive value play, its strategic pivot toward the "Medical-Nursing Business" is seen as a key long-term growth driver. The following is a detailed breakdown of analyst sentiment and market positioning:

1. Core Institutional Perspectives on the Company

Dominance in the Aging Society Market: Most analysts highlight the company's robust business model centered on the rental of nursing beds. According to recent fiscal year data (FY2024 ending March), the Medical-Nursing segment continues to be the primary profit engine. Analysts from firms such as Shared Research and Japanese domestic brokerages note that the recurring revenue from the rental model provides a high level of cash flow stability that is rare in the traditional furniture sector.
Focus on Shareholder Returns: Analysts are particularly positive about the company's proactive capital policy. France Bed has committed to a progressive dividend policy. For the fiscal year ended March 2024, the company maintained an attractive payout ratio, and its history of share buybacks is viewed as a sign of management’s confidence in its intrinsic value.
Margin Improvements via Digitalization: Recent reports emphasize the company's efforts to implement RFID and automated logistics in its "Linen Supply" and rental cleaning processes. Analysts believe these technological upgrades are essential to combat rising labor costs in Japan and will lead to improved operating margins in the 2025-2026 period.

2. Stock Rating and Valuation Metrics

Market consensus for 7840 currently leans toward a "Hold" or "Outperform" depending on the investor's horizon:
Valuation Multiples: The stock is frequently cited as "undervalued" based on traditional metrics. As of the latest quarterly filings, the Price-to-Book (P/B) ratio remains near or below 1.0x, a level that often attracts value investors and potential institutional pressure for "capital efficiency" improvements in line with Tokyo Stock Exchange (TSE) directives.
Dividend Yield: With a dividend yield often hovering between 3.5% and 4.2% (based on recent price fluctuations and the annual dividend of approximately 38-40 JPY per share), analysts view it as a top-tier "yield play" within the Small-Cap Value universe.
Target Prices: Consensus target prices suggest a modest upside of 10-15% from current levels (around 1,100 - 1,250 JPY), reflecting steady growth rather than explosive tech-like appreciation.

3. Analyst-Identified Risk Factors

Despite the stable outlook, analysts warn of several headwinds that could cap the stock's performance:
Regulatory Changes in Nursing Care Insurance: The most significant risk identified by analysts is the periodic revision of Japan's Long-term Care Insurance system. Any reduction in reimbursement rates for bed rentals would directly impact the company’s top-line revenue.
Raw Material and Logistics Inflation: Analysts note that the "Home Interior" (Furniture) segment is sensitive to the cost of imported wood and steel, as well as energy costs. While the company has implemented price hikes, there is a limit to how much cost can be passed to consumers without affecting volume.
Demographic Labor Shortage: The nursing care industry faces a chronic shortage of workers. Analysts worry that if the company’s B2B clients (nursing homes) struggle to staff their facilities, the demand for new equipment installations could experience temporary plateaus.

Summary

The prevailing view among Japanese market analysts is that France Bed Holdings is a "Steady Compounded". It is favored by income-oriented investors for its defensive qualities in a volatile macro environment and its exposure to Japan's inevitable demographic shifts. While it lacks the high-growth profile of a tech stock, its strong balance sheet, high dividend yield, and leadership in the nursing rental market make it a staple for value-focused portfolios entering the latter half of 2024 and 2025.

Further research

France Bed Holdings Co., Ltd. (7840) Frequently Asked Questions

What are the primary investment highlights for France Bed Holdings Co., Ltd., and who are its main competitors?

France Bed Holdings Co., Ltd. is a leading Japanese company specializing in high-quality beds, furniture, and medical nursing equipment. A key investment highlight is its strong presence in the silver market; the company is a pioneer in the nursing bed rental business, benefiting significantly from Japan's aging population. Their business model combines stable recurring revenue from rentals with high-margin luxury furniture sales.
Main competitors in the bedding and furniture sector include Nitori Holdings and Paramount Bed Holdings (specifically in the medical bed segment), as well as premium international brands like Simmons and Sealy.

Are the latest financial results for France Bed Holdings healthy? How are the revenue, net income, and debt levels?

Based on the fiscal year ending March 2024 and recent quarterly filings, France Bed Holdings maintains a stable financial profile. For FY2024, the company reported net sales of approximately ¥55.8 billion, representing a steady year-on-year increase. Net income attributable to owners of the parent reached approximately ¥3.1 billion.
The company maintains a healthy balance sheet with a high equity ratio (often exceeding 60%), indicating low financial risk. Their debt-to-equity ratio remains conservative, as the nursing rental business generates consistent cash flow to fund operations and dividends.

Is the current valuation of 7840 stock high? How do the PER and PBR compare to the industry?

As of mid-2024, France Bed Holdings (7840) typically trades at a Price-to-Earnings (PER) ratio in the range of 12x to 15x, which is generally considered reasonable or slightly undervalued compared to the broader Japanese retail and medical equipment sectors. Its Price-to-Book (PBR) ratio often hovers around 0.9x to 1.1x.
Compared to high-growth furniture retailers, France Bed offers a more value-oriented proposition with a focus on dividend yield, which frequently stays above 3%, making it attractive to income-focused investors.

How has the 7840 stock price performed over the past year compared to its peers?

Over the past 12 months, France Bed's stock has shown resilient performance, often tracking the Nikkei 225 but with lower volatility. While it may not see the explosive growth of tech stocks, it has outperformed several traditional furniture retailers due to the defensive nature of its medical care division. Investors often turn to 7840 during market uncertainty because of its consistent shareholder return policy and essential service offerings in the healthcare space.

Are there any recent industry trends or news affecting France Bed Holdings?

The most significant tailwind is the revision of Long-term Care Insurance in Japan, which influences the demand for nursing bed rentals. Positive adjustments in reimbursement rates or expanded coverage for home-care equipment directly benefit their Medical Services segment. Additionally, the recovery in the hospitality industry (hotels) has led to increased demand for commercial-grade bedding, providing a boost to their furniture wholesale division.

Have large institutional investors been buying or selling 7840 stock recently?

France Bed Holdings is characterized by stable institutional ownership, including Japanese banks and insurance companies. Recent filings indicate that the company is active in share buybacks, a move highly favored by institutional investors as it improves earnings per share (EPS). Foreign institutional participation has remained steady, attracted by the company's ESG initiatives and its alignment with the "Silver Economy" structural growth theme in Japan.

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).

Learn more

How do I buy stock tokens and trade stock perps on Bitget?

To trade France Bed Holdings Co., Ltd. (7840) and other stock products on Bitget, simply follow these steps: 1. Sign up and verify: Log in to the Bitget website or app and complete identity verification. 2. Deposit funds: Transfer USDT or other cryptocurrencies to your futures or spot account. 3. Find trading pairs: Search for 7840 or other stock token/stock perps trading pairs on the trading page. 4. Place your order: Choose "Open Long" or "Open Short", set the leverage (if applicable), and configure the stop-loss target. Note: Trading stock tokens and stock perps involves high risk. Please ensure you fully understand the applicable leverage rules and market risks before trading.

Why buy stock tokens and trade stock perps on Bitget?

Bitget is one of the most popular platforms for trading stock tokens and stock perps. Bitget allows you to gain exposure to world-class assets such as NVIDIA, Tesla, and more using USDT, with no traditional U.S. brokerage account required. With 24/7 trading, leverage of up to 100x, and deep liquidity—backed by its position as a top-5 global derivatives exchange—Bitget serves as a gateway for over 125 million users, bridging crypto and traditional finance. 1. Minimal entry barrier: Say goodbye to complex brokerage account opening and compliance procedures. Simply use your existing crypto assets (e.g., USDT) as margin to access global equities seamlessly. 2. 24/7 trading: Markets are open around the clock. Even when U.S. stock markets are closed, tokenized assets allow you to capture volatility driven by global macro events or earnings reports during pre-market, after-hours, and holidays. 3. Maximized capital efficiency: Enjoy leverage of up to 100x. With a unified trading account, a single margin balance can be used across spot, futures, and stock products, improving capital efficiency and flexibility. 4. Strong market position: According to the latest data, Bitget accounts for approximately 89% of global trading volume in stock tokens issued by platforms such as Ondo Finance, making it one of the most liquid platforms in the real-world asset (RWA) sector. 5. Multi-layered, institutional-grade security: Bitget publishes monthly Proof of Reserves (PoR), with an overall reserve ratio consistently exceeding 100%. A dedicated user protection fund is maintained at over $300 million, funded entirely by Bitget's own capital. Designed to compensate users in the event of hacks or unforeseen security incidents, it is one of the largest protection funds in the industry. The platform uses a segregated hot and cold wallet structure with multi-signature authorization. Most user assets are stored in offline cold wallets, reducing exposure to network-based attacks. Bitget also holds regulatory licenses across multiple jurisdictions and partners with leading security firms such as CertiK for in-depth audits. Powered by a transparent operating model and robust risk management, Bitget has earned a high level of trust from over 120 million users worldwide. By trading on Bitget, you gain access to a world-class platform with reserve transparency that exceeds industry standards, a protection fund of over $300 million, and institutional-grade cold storage that safeguards user assets—allowing you to capture opportunities across both U.S. equities and crypto markets with confidence.

TSE:7840 stock overview